Inagene Diagnostics Inc.

Your first step toward personalized medicine. We help you learn what pain medications to avoid, what to use with caution and what type of cannabis is best.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Toronto, ON, Canada
  • Currency CAD
  • Founded November 2018
  • Employees 7
  • Incorporation Type C-corp
  • Website inagene.com

Company Summary

Inagene Diagnostics Inc. is the only company focused on using genetics for pain management.

Its the only pain management decision support tool covering:
-Comprehensive prescription and non-prescription drugs
-Treatments for related co-morbidities such as mental health/mood disorders
-Personal cannabis metabolism with 9 recommendation profiles

Comprehensive research based findings on the genetic basis of opioid and cannabis dependency

Team

  • Nancy White
    CEO

    +22-year track record of commercial success in sales, marketing, operations and strategy in the healthcare, and technology sectors at Novartis, Allergan, Eli Lilly and Corel Corporation

  • Sigrun Watson
    Vice President, Marketing & Sales

    Sigrun is an experienced healthcare commercialization professional, with over 2 decades of marketing, sales, product and program launch, patient support and training leadership. She is an innovative leader, who always seeks to provide the best patient care and user experience possible. Sigrun spent the past 4 years working in oncology, across several complex tumor sites. She worked at Eisai, Novartis, GSK, Nycomed and Eli Lilly.

Advisors

  • Peter Brenders, MBA, Strategic Advisor
    Unconfirmed
    Don Wright

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free